Abstract
This study was performed to evaluate the implication of anti-H. pylori IgG positivity when CLOtest, histological test, and culture in the antrum and body are all negative, and to find out the specific disease category that is more affected by the hostile relationship of atrophic gastritis and intestinal metaplasia (IM) with H. pylori. Four hundred thirty-six patients (84 controls, 69 with duodenal ulcer, 96 with benign gastric ulcer, 43 with dysplasia, 144 with gastric cancer), who had not received any eradication therapy, were divided into three groups according to H. pylori test: CLOtest or histological H. pylori-positive group (group A; 294 cases), only anti-H. pylori IgG-positive group (group B; 62 cases), and anti-H. pylori IgG-negative group (group C; 80 cases). The grade of neutrophil and monocyte infiltration, atrophic gastritis, and IM was compared according to the updated Sydney system classification. Neutrophil and monocyte infiltrations were significantly severe in the group A. In contrast, the grade of atrophic gastritis and IM in the antrum was significantly higher in group B than the other two groups, A or C. When patients were divided according to the disease outcome in each group, the grade of IM in the body was statistically higher only in the patients with cancer or dysplasia in group B. These results suggest that anti-H. pylori IgG positivity with all negative invasive H. pylori tests represents past infection with H. pylori rather than a false negative, especially in the case of dysplasia and gastric cancer.
Similar content being viewed by others
References
Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ (1991) Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 83:1734–1739
Sipponen P, Hyvarinen H (1993) Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl 196:3–6
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789
Eid R, Moss SF (2002) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 346:65–67
Sipponen P (2001) Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 32:196–202
Malaty HM, Nyren O (2003) Epidemiology of Helicobacter pylori infection. Helicobacter 8(Suppl 1):8–12
Bae JM, Won YJ, Jung KW, Park JG (2002) Annual report of the Korea central cancer registry program 2000; based on registered data from 131 hospitals. Cancer Resear Treat 34:77–83
Kim JH, Kim HY, Kim NY, et al. (2001) Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 16:969–975
Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT (1995) Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 109:136–141
Fabre R, Sobhani I, Laurent-Puig P, et al. (1994) Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: Comparison with culture, rapid urease test, and histopathological tests. Gut 35:905–908
Loffeld RJ, Stobberingh E, Flendrig JA, Arends JW (1991) Helicobacter pylori in gastric biopsy specimens. Comparison of culture, modified Giemsa stain, and immunohistochemistry. A retrospective study. J Pathol 165:69–73
Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, Luijt DS, Meyer BC, Kleibeuker JH (1996) Diagnostic tests for Helicobacter pylori: A prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 91:2125–2129
Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH (1991) Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 101:167–174
Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R, Kosunen TU (2000) Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: Comparison of histology,13C-urea breath test, and serology. Scand J Gastroenterol 35:138–141
Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi C, Perna F, Delle Fave G, Annibale B (2004) Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 9:436–442
Testoni PA, Bonassi U, Bagnolo F, Colombo E, Scelsi R (2002) In diffuse atrophic gastritis, routine histology underestimates Helicobacter pylori infection. J Clin Gastroenterol 35:234–239
Testoni PA, Colombo E, Cattani L, Longhi M, Bagnolo F, Lella F, Buizza M, Scelsi R (1996) Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organisms. J Clin Gastroenterol 22:182–185
El-Zimaity HM, Graham DY (1999) Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: Role of the Sydney System. Hum Pathol 30:72–77
Yousfi MM, El-Zimaity HM, Cole RA, Genta RM, Graham DY (1996) Detection of Helicobacter pylori by rapid urease tests: Is biopsy size a critical variable? Gastrointest Endosc 43:222–224
Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L (2005) A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: A report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol 40:302–311
Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M (2004) Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109:138–143
Price AB (1991) The Sydney System: Histological division. J Gastroenterol Hepatol 6:209–222
Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, Virtamo J, Haapiainen R, Rautelin H (2003) Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 111:619–624
MacOni G, Vago L, Galletta G, Imbesi V, Sangaletti O, Parente F, Cucino C, Bonetto S, Porro GB (1999) Is routine histological evaluation an accurate test for Helicobacter pylori infection? Aliment Pharmacol Ther 13:327–331
Evans DJ Jr, Evans DG, Graham DY, Klein PD (1989) A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 96:1004–1008
Larkin CJ, Watson RGP, Sloan JM, Stevenson M, Ardill JE, Buchanan D (2000) Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scand J Gastroenterol 35:578–582
Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY (1998) Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 27:321–326
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kang, H.Y., Kim, N., Park, Y.S. et al. Progression of Atrophic Gastritis and Intestinal Metaplasia Drives Helicobacter pylori Out of the Gastric Mucosa. Dig Dis Sci 51, 2310–2315 (2006). https://doi.org/10.1007/s10620-006-9276-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9276-0